Inventor · disambiguated record
Jae Young Seong
Also filed as: SEONG JAE YOUNG
12 granted patents·11 pending applications·71 citations·filing 2003–2025
90Inventor score
Top patents by PatentIndex Score
23 records- 0196US11739141B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2020·Granted Aug 29, 2023·7 cites·16 claims
- 0294US11560425B2Use of anti-FAM19A5 antibodies for treating cancersNEURACLE SCIENCE CO LTD·Filed 2018·Granted Jan 24, 2023·12 cites·20 claims
- 0394US11332521B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2017·Granted May 17, 2022·12 cites·20 claims
- 0494US10640557B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2017·Granted May 5, 2020·11 cites·18 claims
- 0593US9579398B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2013·Granted Feb 28, 2017·22 cites·24 claims
- 0685US12435130B2Pharmaceutical use of FAM19A5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2023·Granted Oct 7, 2025·0 cites·15 claims
- 0784US2025236663A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 0878US12202889B2Anti-family with sequence similarity 19, member A5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2022·Granted Jan 21, 2025·0 cites·16 claims
- 0978US10385098B2Agonist of spexin-based galanin type 2 receptor and use thereofNEURACLE SCIENCE CO LTD·Filed 2016·Granted Aug 20, 2019·3 cites·20 claims
- 1075US2023348584A1Use of anti-fam19a5 antibodies for treating cancersNEURACLE SCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 1175US2025263479A1Pharmaceutical use of fam19a5 involved in regulating gliogenesisNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 1271US12072339B2Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment and diagnosis of mood disordersNEURACLE SCIENCE CO LTD·Filed 2018·Granted Aug 27, 2024·1 cites·14 claims
- 1371US11248023B2Agonist of spexin-based galanin type 2 receptor and use thereofNEURACLE SCIENCE CO LTD·Filed 2019·Granted Feb 15, 2022·1 cites·20 claims
- 1471US2025353902A1Anti-family with sequence similarity 19, member a5 antibodies and method of use thereofNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 1565US2025289880A1Use of anti-fam19a5 antibodies for treating cancersNEURACLE SCIENCE CO LTD·Filed 2025·Application pending·0 cites
- 1665US2022242910A1Agonist of spexin-based galanin type 2 receptor and use thereofNEURACLE SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 1765US2025067755A1Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment and diagnosis of mood disordersNEURACLE SCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 1858US7285528B2Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereofNEUROGENEX CO LTD·Filed 2003·Granted Oct 23, 2007·2 cites·3 claims
- 1958US2024238445A1Inhibitors and uses thereofNEURACLE SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 2056US2025333441A1Polypeptide inhibitors and uses thereofNEURACLE SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 2156US2024175880A1Lrrc4 family mimic molecules and diagnostic uses thereofNEURACLE SCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 2252US2023104540A1Use of anti-fam19a1 antagonists for treating central nervous system diseasesNEURACLE SCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 2338US9556242B2Method for regulating circadian rhythmsSEONG JAE-YOUNG·Filed 2012·Granted Jan 31, 2017·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Jae Young Seong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →